Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 118 (2), 111-9

Purine Analogs as Chemotherapeutic Agents in Leishmaniasis and American Trypanosomiasis

Affiliations
  • PMID: 1906917
Review

Purine Analogs as Chemotherapeutic Agents in Leishmaniasis and American Trypanosomiasis

J J Marr. J Lab Clin Med.

Abstract

The metabolic pathways for purines in parasitic protozoans differ significantly from the corresponding pathways in human beings. Leishmania and Trypanosoma cruzi have particular enzymatic reactions that have relevance for chemotherapy. Certain purine analogs are metabolized by the parasites to nucleotides and aminated to the analogs of adenine nucleotides. These halt protein synthesis and cause the break-down of RNA. The most important purine analogs with respect to chemotherapeutic potential are the pyrazolo [3,4-D]-pyrimidines. The prototype, allopurinol, is nontoxic to human beings and is aminated to adenine nucleotide analogs by the organism. Studies in vitro and in vivo have demonstrated its antiparasitic action and led to its development as a chemotherapeutic agent for diseases caused by these organisms. Clinical investigations now have demonstrated the therapeutic efficacy of allopurinol in cutaneous leishmaniasis caused by Leishmania braziliensis and in chronic Chagas' Disease.

Similar articles

See all similar articles

Cited by 20 PubMed Central articles

See all "Cited by" articles
Feedback